HomeBiotechnology mRNA Vaccines and Therapeutics Market Trends, Growth, & Share-2031
mRNA Vaccines and Therapeutics Market Size, Share & Trends Analysis Report By Applications (COVID-19 mRNA vaccines, Non-COVID-19 mRNA vaccines), By mRNA type (COVID-19, Non-COVID-19) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031
mRNA Vaccines and Therapeutics Market, By Applications (2021-2031)
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
mRNA Vaccines and Therapeutics Market, By mRNA type (2021-2031)
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
Regional mRNA Vaccines and Therapeutics Market
North America
North America mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
North America mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
U.S.
U.S. mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
U.S. mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
Canada
Europe
Europe mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
Europe mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
U.K.
U.K. mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
U.K. mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe
APAC
APAC mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
APAC mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
China
China mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
China mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific
Middle East and Africa
Middle East and Africa mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
Middle East and Africa mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
UAE
UAE mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
UAE mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA
LATAM
LATAM mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
LATAM mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
Brazil
Brazil mRNA Vaccines and Therapeutics Market, By Applications
COVID-19 mRNA vaccines
Commercialized Vaccines
Pipeline Vaccines
Non-COVID-19 mRNA vaccines
Oncology
Infectious Diseases
Other Diseases
Brazil mRNA Vaccines and Therapeutics Market, By mRNA type
COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA
Non-COVID-19
Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA)
Mexico
Argentina
Chile
Colombia
Rest of LATAM
Purchase Benefits
Eligible for a free updated report next year
Completely customizable scope
30% discount on your next purchase
Dedicated account manager
Query resolution within 24 hours
Permission to print the report
We are featured on :
Sample Details
You will receive a link to download the sample pages on your email immediately after filling out a form
A sample report will help you understand the structure of our full report
The sample shared will be for our off-the-shelf market report
The off-the-shelf report is curated considering a broader audience for this market, we have insights extending well beyond the scope of this report. Please reach out to discuss
Should the sample pages not contain the specific information you seek, we extend the option to request additional details, which our dedicated team will incorporate.
The sample is free of cost, while the full report is available for a fee.